Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylene Blue Photodynamic Therapy for Deep Tissue Abscesses
NCT02240498Phase 1Completed
- Sponsor
- University of Rochester
- Start
- Sep 2014
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of methylene blue in abscess (6 arms), sponsored by University of Rochester. Primary endpoints: Number of study-related serious adverse events at 14 days, Number of patients with study-related unanticipated adverse events at 14 days and 5 more. Started Sep 2014; status: completed.
02
Drugs
methylene blue
03
Conditions
abscess
Beyond the preview
Go deeper on NCT02240498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02240498.